Bank Of America Corp Rapt Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 90,656 shares of RAPT stock, worth $180,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,656

Previous 109,255 17.02%

Holding current value

$180,405

Previous $981,000 71.87%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.89 - $9.38 $53,751 - $174,458	-18,599 Reduced 17.02%	90,656 $276,000
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $108,862 - $419,126	15,846 Added 16.96%	109,255 $981,000
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $224,517 - $506,755	19,904 Added 27.08%	93,409 $2.32 Million
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $1.06 Million - $1.42 Million	-65,731 Reduced 47.21%	73,505 $1.37 Million
Q1 2023 May 12, 2023	SELL	$17.19 - $30.8 $67,917 - $121,690	-3,951 Reduced 2.76%	139,236 $2.55 Million
Q4 2022 Feb 10, 2023	BUY	$16.28 - $24.6 $1.53 Million - $2.31 Million	93,849 Added 190.22%	143,187 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $724,721 - $1.23 Million	40,352 Added 449.05%	49,338 $1.19 Million
Q2 2022 Aug 12, 2022	SELL	$10.26 - $23.59 $278,425 - $640,161	-27,137 Reduced 75.12%	8,986 $163,000
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $784,792 - $1.85 Million	-46,110 Reduced 56.07%	36,123 $794,000
Q4 2021 Feb 08, 2022	BUY	$29.5 - $39.5 $2.16 Million - $2.89 Million	73,102 Added 800.59%	82,233 $3.02 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $36,906 - $48,784	1,236 Added 15.66%	9,131 $283,000
Q2 2021 Sep 13, 2021	BUY	$17.99 - $40.02 $142,031 - $315,957	7,895 New	7,895 $250,000

Others Institutions Holding RAPT

# of Institutions

126

Shares Held

29.1M

Call Options Held

905K

Put Options Held

592K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $59M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Rapt Therapeutics, Inc. Transaction History